FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4385563485> ?p ?o ?g. }

• W4385563485 abstract "Objectives: To develop, evaluate, and explore the use of a pediatric ordinal score as a potential clinical trial outcome metric in children hospitalized with acute hypoxic respiratory failure caused by viral respiratory infections. Design: We modified the World Health Organization Clinical Progression Scale for pediatric patients (CPS-Ped) and assigned CPS-Ped at admission, days 2–4, 7, and 14. We identified predictors of clinical improvement (day 14 CPS-Ped ≤ 2 or a three-point decrease) using competing risks regression and compared clinical improvement to hospital length of stay (LOS) and ventilator-free days. We estimated sample sizes (80% power) to detect a 15% clinical improvement. Setting: North American pediatric hospitals. Patients: Three cohorts of pediatric patients with acute hypoxic respiratory failure receiving intensive care: two influenza (pediatric intensive care influenza [PICFLU], n = 263, 31 sites; PICFLU vaccine effectiveness [PICFLU-VE], n = 143, 17 sites) and one COVID-19 ( n = 237, 47 sites). Interventions: None. Measurements and Main Results: Invasive mechanical ventilation rates were 71.4%, 32.9%, and 37.1% for PICFLU, PICFLU-VE, and COVID-19 with less than 5% mortality for all three cohorts. Maximum CPS-Ped (0 = home at respiratory baseline to 8 = death) was positively associated with hospital LOS ( p < 0.001, all cohorts). Across the three cohorts, many patients’ CPS-Ped worsened after admission (39%, 18%, and 49%), with some patients progressing to invasive mechanical ventilation or death (19%, 11%, and 17%). Despite this, greater than 76% of patients across cohorts clinically improved by day 14. Estimated sample sizes per group using CPS-Ped to detect a percentage increase in clinical improvement were feasible (influenza 15%, n = 142; 10%, n = 225; COVID-19, 15% n = 208) compared with mortality ( n > 21,000, all), and ventilator-free days (influenza 15%, n = 167). Conclusions: The CPS-Ped can be used to describe the time course of illness and threshold for clinical improvement in hospitalized children and adolescents with acute respiratory failure from viral infections. This outcome measure could feasibly be used in clinical trials to evaluate in-hospital recovery." @default.
• W4385563485 created "2023-08-05" @default.
• W4385563485 creator A5006764971 @default.
• W4385563485 creator A5007779144 @default.
• W4385563485 creator A5008379181 @default.
• W4385563485 creator A5009301455 @default.
• W4385563485 creator A5011813076 @default.
• W4385563485 creator A5019369010 @default.
• W4385563485 creator A5019677521 @default.
• W4385563485 creator A5022979690 @default.
• W4385563485 creator A5026626377 @default.
• W4385563485 creator A5029802394 @default.
• W4385563485 creator A5031050078 @default.
• W4385563485 creator A5031874573 @default.
• W4385563485 creator A5035425491 @default.
• W4385563485 creator A5037209289 @default.
• W4385563485 creator A5043871716 @default.
• W4385563485 creator A5045499174 @default.
• W4385563485 creator A5046337695 @default.
• W4385563485 creator A5048932268 @default.
• W4385563485 creator A5064650836 @default.
• W4385563485 creator A5065907654 @default.
• W4385563485 creator A5069821127 @default.
• W4385563485 creator A5070604004 @default.
• W4385563485 creator A5072203438 @default.
• W4385563485 creator A5081936870 @default.
• W4385563485 creator A5083639360 @default.
• W4385563485 creator A5084260960 @default.
• W4385563485 creator A5087750390 @default.
• W4385563485 date "2023-08-04" @default.
• W4385563485 modified "2023-09-25" @default.
• W4385563485 title "The Modified Clinical Progression Scale for Pediatric Patients: Evaluation as a Severity Metric and Outcome Measure in Severe Acute Viral Respiratory Illness" @default.
• W4385563485 cites W2024805813 @default.
• W4385563485 cites W2038981426 @default.
• W4385563485 cites W2074200017 @default.
• W4385563485 cites W2089757710 @default.
• W4385563485 cites W2286228001 @default.
• W4385563485 cites W2348923551 @default.
• W4385563485 cites W2413088853 @default.
• W4385563485 cites W2462164028 @default.
• W4385563485 cites W2518864291 @default.
• W4385563485 cites W2547335699 @default.
• W4385563485 cites W2611140738 @default.
• W4385563485 cites W2797869926 @default.
• W4385563485 cites W2800598627 @default.
• W4385563485 cites W2897603516 @default.
• W4385563485 cites W2943492071 @default.
• W4385563485 cites W2965626469 @default.
• W4385563485 cites W2978883317 @default.
• W4385563485 cites W2990444411 @default.
• W4385563485 cites W3027630905 @default.
• W4385563485 cites W3034858522 @default.
• W4385563485 cites W3036054454 @default.
• W4385563485 cites W3038003713 @default.
• W4385563485 cites W3082108964 @default.
• W4385563485 cites W3111400428 @default.
• W4385563485 cites W3132267494 @default.
• W4385563485 cites W3201297794 @default.
• W4385563485 cites W4205197778 @default.
• W4385563485 cites W4205793223 @default.
• W4385563485 cites W4206068219 @default.
• W4385563485 cites W4211250103 @default.
• W4385563485 cites W4214603305 @default.
• W4385563485 cites W4220851895 @default.
• W4385563485 cites W4224327146 @default.
• W4385563485 cites W4282968796 @default.
• W4385563485 cites W4293678624 @default.
• W4385563485 cites W4317567028 @default.
• W4385563485 doi "https://doi.org/10.1097/pcc.0000000000003331" @default.
• W4385563485 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37539964" @default.
• W4385563485 hasPublicationYear "2023" @default.
• W4385563485 type Work @default.
• W4385563485 citedByCount "0" @default.
• W4385563485 crossrefType "journal-article" @default.
• W4385563485 hasAuthorship W4385563485A5006764971 @default.
• W4385563485 hasAuthorship W4385563485A5007779144 @default.
• W4385563485 hasAuthorship W4385563485A5008379181 @default.
• W4385563485 hasAuthorship W4385563485A5009301455 @default.
• W4385563485 hasAuthorship W4385563485A5011813076 @default.
• W4385563485 hasAuthorship W4385563485A5019369010 @default.
• W4385563485 hasAuthorship W4385563485A5019677521 @default.
• W4385563485 hasAuthorship W4385563485A5022979690 @default.
• W4385563485 hasAuthorship W4385563485A5026626377 @default.
• W4385563485 hasAuthorship W4385563485A5029802394 @default.
• W4385563485 hasAuthorship W4385563485A5031050078 @default.
• W4385563485 hasAuthorship W4385563485A5031874573 @default.
• W4385563485 hasAuthorship W4385563485A5035425491 @default.
• W4385563485 hasAuthorship W4385563485A5037209289 @default.
• W4385563485 hasAuthorship W4385563485A5043871716 @default.
• W4385563485 hasAuthorship W4385563485A5045499174 @default.
• W4385563485 hasAuthorship W4385563485A5046337695 @default.
• W4385563485 hasAuthorship W4385563485A5048932268 @default.
• W4385563485 hasAuthorship W4385563485A5064650836 @default.
• W4385563485 hasAuthorship W4385563485A5065907654 @default.
• W4385563485 hasAuthorship W4385563485A5069821127 @default.
• W4385563485 hasAuthorship W4385563485A5070604004 @default.
• W4385563485 hasAuthorship W4385563485A5072203438 @default.
• W4385563485 hasAuthorship W4385563485A5081936870 @default.
• W4385563485 hasAuthorship W4385563485A5083639360 @default.
• W4385563485 hasAuthorship W4385563485A5084260960 @default.

• next